Aurobindo Pharma's Eugia Pharma unit in Telangana receives a USFDA warning letter after recent inspections, but supply remains unaffected.
SENSEX 77,830.91
NIFTY 24,343.75
CRUDEOIL 7,900.00
+ 79.00
GOLD 153,022.00
Aurobindo Pharma's subsidiary Eugia Pharma receives a U.S. FDA warning letter following previous compliance issues at its…
Aurobindo Pharma's Eugia facility in Hyderabad receives U.S. FDA's "official action indicated" classification, signaling…
Aurobindo Pharma expands its presence in France with the launch of Arrow Pharma Production SAS for generic formulation…
Zydus receives USFDA approval for a surgical imaging drug, Indocyanine Green, with a 180-day exclusivity window for marketing.
Cipla’s Goa facility receives VAI classification from US FDA after April inspection, indicating no regulatory or enforcement…
The United States Food and Drug Administration (U.S. FDA) has issued an Official Action Indicated (OAI) classification to…
